From trigeminal ganglion to cortex: ATG7 emerges as a key integrator of migraine pathways via multi-omics profiling.

Researchers have discovered important clues about what happens in the brain and nerves during migraines by studying genes in both the trigeminal ganglion (a nerve cluster near your temple) and the cortex (outer brain layer). Using advanced genetic analysis, scientists identified 109 genes that are active in both areas during migraines, suggesting that migraines involve coordinated changes in both the peripheral nerves and the brain itself. The study found five key genes that appear central to migraine development, with one called ATG7 emerging as particularly important. ATG7 controls autophagy, a cellular "cleanup" process that removes damaged components from cells. In migraine models, ATG7 was highly active in both brain cells called astrocytes and neurons, and it appeared to increase the autophagy process. This discovery is significant because it shows migraines aren't just about blood vessels or single nerve pathways—they involve complex cellular processes throughout the nervous system. For patients considering acupuncture, this research supports the understanding that migraine is a whole-system disorder affecting multiple cell types and pathways. Acupuncture's effects on pain processing, inflammation, and nervous system regulation may address some of these multi-level mechanisms the study identified. The findings suggest that effective migraine treatment may need to target both central brain processes and peripheral nerve activity simultaneously, which aligns with acupuncture's systemic approach to pain management. When seeking migraine relief through acupuncture, find a licensed acupuncturist with specific training and experience in treating headache disorders.

This multi-omics study integrated human trigeminal ganglion single-nucleus RNA sequencing with cortical expression quantitative trait loci data across eight cell types, employing Mendelian randomization to identify migraine susceptibility genes. Researchers identified 586 migraine-associated genes in TG and 1,108 in cortex, with 109 overlapping genes converging on autophagy and neuroinflammation pathways. Five hub genes (HSP90AB1, EGFR, ERBB3, MET, ATG7) were validated across both tissues. Experimental validation in migraine model mice demonstrated ATG7's prominent expression in cortical astrocytes and neurons. Western blot analysis revealed significantly elevated LC3-II/LC3-I and LC3-II/p62 ratios in the primary sensory cortex, indicating enhanced autophagic flux without obstruction. Clinical implications: migraine pathophysiology involves coordinated central-peripheral mechanisms with cell-type-specific genetic contributions, particularly autophagy dysregulation. These findings support multi-targeted therapeutic approaches that address both neuronal and glial pathways, relevant for understanding acupuncture's neuromodulatory effects on migraine through potential autophagy regulation and neuroinflammation modulation.